ask="1.10"
ask_size="10000"
average_daily_volume="1326630"
bid="0.97"
bid_size="1000"
book_value="0.61"
change="-0.01"
change_from_200_day_moving_average="-1.36"
change_from_50_day_moving_average="0.04"
change_from_52_week_high="-3.92"
change_From_52_week_low="0.51"
change_in_percent="-0.98%"
close="1.01"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.24"
ebitda="-8.78M"
eps_estimate_current_year="-1.12"
eps_estimate_next_quarter="-0.25"
eps_estimate_next_year="0.19"
ex_dividend_date="N/A"
float_shares="7029000"
high="1.02"
high_52_weeks="4.93"
last_trade_date="2/8/2017"
last_trade_price="1.01"
last_trade_size="101"
last_trade_time="3:59pm"
low="0.97"
low_52_weeks="0.50"
market_capitalization="7.21M"
moving_average_200_day="2.37"
moving_average_50_day="0.97"
name="Opexa Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.33"
open="1.01"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-57.42%"
percent_change_from_50_day_moving_average="+4.61%"
percent_change_from_52_week_high="-79.51%"
percent_change_from_52_week_low="+102.00%"
previous_close="1.02"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="5.32"
price_per_book="1.68"
price_per_sales="2.85"
revenue="2.56M"
shares_outstanding="7141000"
short_ratio="0.74"
stock_exchange="NCM"
symbol="OPXA"
volume="190602"
weeks_range_52="0.50 - 4.93"
